Vanda Pharmaceuticals
VNDA
VNDA
136 hedge funds and large institutions have $556M invested in Vanda Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
-5
Holders Change %
-3.55%
% of All Funds
3.39%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
21
Increased
46
Reduced
53
Closed
19
Calls
$721K
Puts
$625K
Net Calls
+$96K
Net Calls Change
-$1.23M
Top Buyers
1 |
1
BlackRock
New York
|
$53.9M |
2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$34.8M |
3 |
AC
3
Armistice Capital
New York
|
$22.5M |
4 |
![]()
4
Fidelity Investments
Boston,
Massachusetts
|
$22.4M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$34.9M |